# Carotid Artery Stenosis

Manage carotid stenosis by first establishing whether a recent ipsilateral retinal or cerebral ischemic event is attributable to the lesion, confirming NASCET-equivalent severity, initiating intensive vascular prevention, and rapidly selecting endarterectomy or stenting only when procedural benefit exceeds risk.

**Clinical question:** How should physicians confirm, risk-stratify, and treat symptomatic or asymptomatic extracranial internal carotid artery stenosis?

Updated: 2026-09-15T22:39:30.992242+00:00

## What matters in practice
- Treat a recent ipsilateral TIA, amaurosis fugax, or nondisabling stroke with associated carotid stenosis as symptomatic disease; revascularization benefit is greatest for 70% to 99% stenosis and is recommended for selected patients with stenosis of at least 50%. [10][21]
- When revascularization is indicated after symptomatic carotid-territory ischemia, complete it within 2 weeks of the index event when clinically feasible. [1][6]
- Use carotid duplex ultrasound as the first noninvasive test, but confirm a potentially intervention-eligible result with CTA or MRA when findings are uncertain or procedural planning is required. [14][23]
- Medical therapy is required whether or not revascularization is performed and includes antiplatelet therapy, intensive dyslipidemia treatment, blood-pressure and diabetes management, smoking cessation, diet, and exercise. [5][6]
- For asymptomatic disease, contemporary medical therapy is associated with an annual stroke risk below 1%; intervention should therefore be restricted to carefully selected patients with severe stenosis and low expected procedural risk. [7][20]

## Determine whether the carotid lesion is symptomatic

The revascularization threshold and urgency depend on a defensible ipsilateral carotid-territory ischemic event.

Classify stenosis as symptomatic when a recent TIA, amaurosis fugax, or nondisabling ischemic stroke is referable to the ipsilateral carotid artery; CREST defined symptomatic status by recent neurologic events and considered events more than 180 days earlier asymptomatic. [21] A focal event in the opposite hemisphere, posterior circulation symptoms, or a nonfocal syndrome should not by itself establish causality for an ipsilateral extracranial internal carotid lesion.

For a patient with recent ipsilateral retinal or cerebral ischemia and an associated stenosis of at least 50%, obtain expedited vascular imaging and begin evaluation for revascularization. The largest benefit is observed with 70% to 99% symptomatic stenosis. [10] Do not delay definitive vascular assessment while awaiting recurrent events: treatment guidance supports revascularization within 2 weeks of the index event. [1][6]
- Recent ipsilateral amaurosis fugax, TIA, or nondisabling stroke plus corresponding stenosis: pursue an urgent symptomatic-stenosis pathway. [21]
- Symptoms more than 180 days before assessment: use an asymptomatic-stenosis risk-benefit framework unless a new ipsilateral event occurs. [21]
- Severe symptomatic stenosis: prioritize a revascularization decision within 2 weeks. [1][6]

*Clinical classification that changes revascularization urgency and expected benefit. [1][6][10][21]*

| Presentation | Operational classification | Next action |
| --- | --- | --- |
| Recent ipsilateral TIA, amaurosis fugax, or nondisabling stroke with associated carotid stenosis | Symptomatic carotid stenosis. [21] | Confirm severity and anatomy promptly; consider revascularization when stenosis is at least 50%, with greatest benefit at 70% to 99%; target treatment within 2 weeks. [1][6][10] |
| No recent neurologic event referable to the artery, including symptoms more than 180 days earlier | Asymptomatic carotid stenosis. [21] | Institute intensive medical therapy; reserve revascularization for selected patients with severe disease, low procedural risk, and favorable competing-risk assessment. [7][20] |

## Confirm severity before committing to revascularization

Use a reproducible stenosis method and avoid making a procedural decision from discordant imaging alone.

Perform carotid duplex ultrasound as the initial noninvasive study for suspected extracranial carotid bifurcation disease. Duplex is widely used as the primary screening test and can efficiently identify patients who need CTA, MRA, or procedural evaluation; diagnostic accuracy is strongest for separating less than 50% from 50% to 99% stenosis. [22][23] In a technically adequate laboratory, Society of Radiologists in Ultrasound criteria use visible plaque plus internal carotid artery peak systolic velocity of 125 to 230 cm/s, an ICA/CCA peak systolic velocity ratio of 2.0 to 4.0, and end-diastolic velocity of 40 to 100 cm/s for 50% to 69% stenosis. [22]

For duplex findings suggesting 70% or greater stenosis, review the full velocity and plaque data rather than a single velocity value. ICA/CCA peak systolic velocity ratio greater than 4.0 supports at least 70% stenosis, while a ratio greater than 5.0 supports at least 90% stenosis in recommended criteria. [14] Velocity thresholds are laboratory- and method-dependent; increasing the threshold increases specificity but decreases sensitivity. [22][23] Therefore, a potentially intervention-eligible duplex result that is technically limited, inconsistent with the clinical syndrome, or affected by heavy calcification warrants CTA or MRA confirmation.

Measure and report angiographic stenosis with the NASCET method when correlating CTA, MRA, or digital subtraction angiography to trial-based treatment thresholds. A 70% NASCET stenosis approximates 82% using ECST measurement; mixing these systems can misclassify a patient across an intervention threshold. [24] CTA evaluates intracranial circulation but is susceptible to calcific plaque artifact and requires intravenous contrast and radiation; MRA avoids radiation but may have motion and acquisition limitations. [24]
- Duplex result below 50% stenosis: a carotid revascularization indication is not established by the symptomatic thresholds described in current reviews. [10][23]
- Duplex result consistent with 50% to 69% symptomatic stenosis: confirm severity and correlate with the ipsilateral ischemic syndrome before procedural selection. [10][22][23]
- Duplex result consistent with 70% or greater stenosis: obtain prompt multidisciplinary procedural assessment after confirmatory anatomic imaging when needed. [1][6][14]

### Imaging pitfalls that alter the next test

Duplex does not image the intracranial ICA or aortic arch, and acoustic shadowing or operator-dependent velocity acquisition can impair grading. [14][24] CTA can underestimate stenosis in the setting of calcified plaque artifact, whereas time-of-flight MRA is susceptible to motion artifact. [24] If duplex and cross-sectional imaging disagree near a treatment threshold, resolve the discrepancy with review by the vascular imaging team and use a consistent NASCET-equivalent measurement for the revascularization decision. [23][24]

*Duplex findings used to grade internal carotid stenosis; correlate with visible plaque and laboratory-specific validation. [14][22]*

| Estimated ICA stenosis | Duplex parameters | Decision implication |
| --- | --- | --- |
| 50% to 69% | Visible plaque, ICA peak systolic velocity 125-230 cm/s, ICA/CCA peak systolic velocity ratio 2.0-4.0, and ICA end-diastolic velocity 40-100 cm/s. [22] | In symptomatic patients, establish NASCET-equivalent severity and clinical concordance before considering revascularization. [10][24] |
| At least 70% | ICA/CCA peak systolic velocity ratio greater than 4.0 supports at least 70% stenosis. [14] | For a recent ipsilateral ischemic event, expedite revascularization assessment and aim for treatment within 2 weeks. [1][6][10] |
| At least 90% | ICA/CCA peak systolic velocity ratio greater than 5.0 supports at least 90% stenosis. [14] | Treat as severe disease after confirmation of anatomy and procedural suitability. [6][14] |

## Implement intensive vascular prevention regardless of procedure

Revascularization treats a focal lesion; it does not replace secondary or primary atherosclerotic prevention.

Prescribe the core elements of vascular disease management for every patient with carotid atherosclerosis: antiplatelet therapy, aggressive dyslipidemia treatment, blood-pressure treatment to national targets, diabetes treatment to national targets, smoking cessation, dietary modification, and exercise. [5] Continue this approach before and after CEA or CAS because optimal medical therapy is a critical component of every revascularization strategy. [6]

For asymptomatic stenosis, use the low contemporary stroke rate on optimal medical therapy as the comparator for an elective procedure. Reported annual stroke risk is below 1% with optimal medical therapy, while pivotal asymptomatic revascularization trials predated current atherosclerosis treatment standards. [7][20] This uncertainty increases the importance of individualized assessment of competing comorbidity, anticipated longevity, lesion severity, and the center's actual perioperative outcomes.
- Document antiplatelet use, lipid-lowering treatment, blood-pressure control, diabetes management, smoking status, diet, and exercise at the initial consultation and at longitudinal follow-up. [5][6]
- Do not offer an asymptomatic intervention solely because a stenosis is detected; compare expected procedural harm against a medical-therapy stroke risk below 1% per year. [7][20]
- Use local outcome data in procedural selection: historical guideline thresholds cited for acceptable perioperative risk are below 6% for symptomatic and below 3% for asymptomatic patients. [8]

*Medical treatment and procedural risk context by symptomatic status. [5][7][8][20]*

| Clinical state | Required baseline management | Risk context for intervention |
| --- | --- | --- |
| Symptomatic carotid stenosis | Antiplatelet therapy, aggressive dyslipidemia treatment, treatment of hypertension and diabetes to national targets, smoking cessation, diet, and exercise. [5] | Historical guidance uses a perioperative risk ceiling below 6%; benefit is greatest in severe symptomatic stenosis. [8][10] |
| Asymptomatic carotid stenosis | The same intensive vascular prevention package applies. [5][6] | Optimal medical therapy is associated with annual stroke risk below 1%; historical guidance uses a perioperative stroke, MI, and death risk threshold below 3%. [7][8][20] |

## Select endarterectomy or stenting by symptom status and procedural risk

Both procedures prevent stroke in selected patients, but procedure selection requires anatomy, age, comorbidity, and center expertise.

Carotid endarterectomy and carotid artery stenting are the principal revascularization procedures for extracranial carotid stenosis. [2][3] In symptomatic disease, current recommendations support revascularization in patients with at least 50% stenosis, especially 70% to 99%, and recommend performing it within 2 weeks of the index event. [6][10] Use CEA or CAS only after confirming that the lesion explains the ipsilateral event and that expected procedural risk is acceptable.

CEA is the established surgical option; CAS was developed particularly as an alternative for patients at increased surgical risk for perioperative complications from CEA. [6] CAS introduces a catheter-related risk of cerebral embolization and consequent perioperative stroke. [17] In CREST, symptomatic patients could enter with at least 50% angiographic stenosis, at least 70% by ultrasound, or at least 70% by CTA or MRA, demonstrating that imaging modality and measurement convention must be reconciled before assigning a procedural indication. [21]

For asymptomatic disease, revascularization remains selective rather than routine. Multispecialty guidance cited a class IIa recommendation for revascularization of greater than 70% asymptomatic ICA stenosis when perioperative stroke, MI, and death risk is low. [7] ACT I found protected CAS noninferior to CEA among low-risk asymptomatic patients, but did not include a contemporary medical-therapy-only control group. [20] The decision is therefore not simply CEA versus CAS; first determine whether either procedure adds sufficient benefit beyond intensive medical treatment.
- Recent symptomatic stenosis of 70% to 99%: prioritize revascularization evaluation; do not defer beyond 2 weeks without a patient-specific reason. [1][6][10]
- Recent symptomatic stenosis of 50% to 69%: consider revascularization only after confirming the lesion's causal relevance and procedural acceptability. [10][21]
- Asymptomatic stenosis greater than 70%: consider CEA or protected CAS only when procedural risk is low and individualized benefit is credible against contemporary medical therapy. [7][20]
- Increased surgical risk for CEA: evaluate CAS as an alternative, accounting for embolic stroke risk and operator experience. [6][17]

### Timing and perioperative tradeoffs

The timing rule is strongest for symptomatic disease: perform revascularization within 2 weeks of the index event when feasible. [1][6] The procedural threshold must include the expected local complication rate. Historical guidance sets upper limits of 6% perioperative risk for symptomatic patients and 3% for asymptomatic patients, emphasizing why intervention should be performed in programs able to document outcomes. [8]

*Procedure-selection framework for carotid revascularization. [6][7][10][17][20]*

| Scenario | Preferred decision | Reasoning and constraints |
| --- | --- | --- |
| Recent ipsilateral ischemic event and confirmed 70%-99% stenosis | Proceed urgently to CEA-versus-CAS assessment; target revascularization within 2 weeks. [6][10] | This group has the greatest documented benefit from revascularization; procedural risk must remain acceptable. [1][8][10] |
| Recent ipsilateral ischemic event and confirmed 50%-69% stenosis | Individualize revascularization after confirming concordance and anatomy. [10] | Guidelines support revascularization in selected symptomatic patients with at least 50% stenosis, but benefit is greatest with 70%-99%. [10] |
| Increased surgical risk for CEA | Consider CAS in an experienced program. [6] | CAS was developed for patients at higher surgical risk from CEA, but catheterization can cause cerebral embolization and perioperative stroke. [6][17] |
| Asymptomatic stenosis greater than 70% and low procedural risk | Consider revascularization only after shared risk-benefit assessment. [7][20] | CAS with embolic protection was noninferior to CEA in ACT I, but the contemporary medical-therapy-only comparison remains central because medical-treatment stroke risk is below 1% annually. [20] |

## Reassess symptoms, imaging validity, and procedural candidacy over time

Follow-up should detect a new ipsilateral event, a flawed severity estimate, or a change in the medical-versus-procedural balance.

At each follow-up, ask specifically about new ipsilateral transient monocular visual loss, focal hemispheric deficits, or nondisabling stroke. A new event reclassifies a previously asymptomatic lesion as symptomatic and should trigger expedited repeat vascular imaging and revascularization review under the 2-week timing principle. [1][6][21] Reconcile any new imaging with prior NASCET-equivalent measurements rather than comparing percentages derived from different methods. [24]

Repeat or escalate imaging when the initial duplex study is technically limited, when cross-sectional imaging and duplex are discordant near an intervention threshold, or when lesion progression would change candidacy. Duplex accuracy is influenced by velocity threshold selection, plaque visualization, operator performance, contralateral occlusion, and inability to distinguish subtotal from total occlusion reliably in some cases. [22][23][24] CTA or MRA can provide confirmatory extracranial and intracranial anatomic information, with modality-specific limitations considered before ordering. [14][24]

For patients managed medically, reassess adherence to antiplatelet therapy, dyslipidemia treatment, blood-pressure and diabetes control, smoking cessation, diet, and exercise rather than treating a stable imaging percentage as the only outcome. [5][6] For asymptomatic patients, a new procedure discussion should explicitly revisit the low stroke rate on optimal medical therapy, procedural risk, and comorbid competing risk. [7][20]
- New ipsilateral retinal or hemispheric ischemia: repeat vascular assessment promptly and seek revascularization review within the symptomatic 2-week window. [1][6]
- Imaging disagreement near 50% or 70% thresholds: obtain or review CTA/MRA using NASCET-equivalent measurement rather than relying on an isolated duplex velocity. [23][24]
- Stable asymptomatic disease: continue intensive medical therapy and reassess procedural benefit only if patient risk, severity, or local procedural risk changes. [5][7][20]

*Escalation triggers during carotid stenosis follow-up. [1][5][6][23][24]*

| Trigger | Immediate action | What changes |
| --- | --- | --- |
| New ipsilateral TIA, amaurosis fugax, or nondisabling stroke | Obtain expedited carotid imaging and revascularization assessment. [1][6][21] | The lesion becomes symptomatic, and revascularization should be considered within 2 weeks. [1][6] |
| Duplex result is limited or conflicts with clinical presentation | Confirm with CTA or MRA and apply NASCET-equivalent measurement. [14][23][24] | Prevents misclassification across the 50% and 70% decision thresholds. [10][24] |
| Asymptomatic patient considering elective intervention | Reassess medical therapy, estimated procedural risk, comorbidity, and expected benefit. [5][7][20] | Contemporary medical-treatment stroke risk below 1% per year raises the threshold for intervention. [20] |

## References
1. Carotid Stenosis — www.nejm.org — https://www.nejm.org/doi/pdf/10.1056/NEJMcp1214999
2. Carotid Endarterectomy and Carotid Artery Stenting in the ... — jamanetwork.com — https://jamanetwork.com/journals/jama/fullarticle/2654384
3. Stenting versus Endarterectomy for Treatment of Carotid-Artery ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa0912321
4. Protected Carotid-Artery Stenting versus Endarterectomy in High ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa040127
5. How Recent Data Have Impacted the Treatment of Internal Carotid Artery Stenosis — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2014.12.045
6. Carotid Artery Stenting: JACC State-of-the-Art Review — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2022.05.007
7. Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis: 
JACC Review Topic of the Week — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2019.11.054
8. Optimal Treatment of Carotid Artery Disease — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2007.10.052
9. Carotid Artery Stenting | Stroke — stroke.ahajournals.org — http://stroke.ahajournals.org/cgi/content/full/37/9/2400
10. Symptomatic Cervical Carotid Artery Stenosis:... : Annals of ... - Ovid — journals.lww.com — https://journals.lww.com/annalsofian/fulltext/2025/01000/symptomatic_cervical_carotid_artery_stenosis_.1.aspx
11. Recent concepts in the management of extracranial... : Neurology India — journals.lww.com — https://journals.lww.com/neur/fulltext/2011/59030/recent_concepts_in_the_management_of_extracranial.13.aspx
12. Carotid-Artery Stenting or Carotid Endarterectomy... : New England Journal of Medicine — journals.lww.com — https://journals.lww.com/00006024-202511060-00014
13. Global trends in the management of carotid artery stenosis - Ovid — journals.lww.com — https://journals.lww.com/brci/fulltext/9900/global_trends_in_the_management_of_carotid_artery.55.aspx
14. Duplex Ultrasound Criteria for Defining the Severity of Carotid Stenosis - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0890509606623005
15. Predictive Ability of Duplex Ultrasonography for Internal Carotid Artery Stenosis of 70%–99%: A Comparative Study - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0890509606616646
16. CT Angiography–derived Duplex Ultrasound Velocity Criteria in Patients with Carotid Artery Stenosis - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0890509614000259
17. Treatment of carotid stenosis: surgery and stent in comparison — academic.oup.com — https://academic.oup.com/eurheartjsupp/article/23/Supplement_E/E91/6386347
18. Clinical Outcomes and Complications of Carotid Artery Stenting With ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111/jon.70041
19. Carotid artery stenting vs. endarterectomy - Oxford Academic — academic.oup.com — https://academic.oup.com/eurheartj/article/30/22/2693/478990
20. Asymptomatic Carotid Trial I - American College of Cardiology — www.acc.org — https://www.acc.org/latest-in-cardiology/clinical-trials/2016/02/16/23/41/act-i
21. Carotid Revascularization Endarterectomy vs. Stenting Trial - American College of Cardiology — www.acc.org — https://www.acc.org/latest-in-cardiology/clinical-trials/2011/06/06/14/21/crest-2010
22. Reappraisal of velocity criteria for carotid bulb/internal carotid artery stenosis utilizing high-resolution B-mode ultrasound validated with computed tomography angiography - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC3506188
23. Duplex ultrasound for diagnosing symptomatic carotid stenosis in the extracranial segments - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9272405
24. Why are we still debating criteria for carotid artery stenosis? — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7607093

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.